SEP 16, 2015 04:46 PM PDT

Stem Cell Suffocation

Pancreatic cancer stem cells (PancSCs) are virtually addicted to oxygen-based metabolism, and could be “suffocated” with a drug already used to treat diabetes, according to a new study reported in Drug Discovery & Development
Pancreatic cancer may succumb to having its energy supply cut off. 
Cancer cells usually rely on glycolysis, the type of metabolism that does not use oxygen to generate energy. However, researchers from Queen Mary University of London’s Barts Cancer Institute and the Spanish National Cancer Research Centre (CNIO) in Madrid have now found that not all cancer cells are alike when it comes to metabolism
 
PancSCs can use a more efficient form of metabolism, called oxidative phosphorylation or OXPHOS, which does use oxygen. OXPHOS uses a part of the cell called mitochondria, which can be targeted with anti-diabetic drug, metformin. Some PancSCs can escape this treatment by being much more flexible in their metabolism, leading to a recurrence of the cancer. The investigators discovered a method of preventing such resistance and forcing all PancSCs to keep using OXPHOS. They think that the new discovery could be used to develop treatments to stop the stem cells from using oxygen and preventing cancer returning after conventional treatment. A clinical trial is planned for later next year.
 
According to Dr Patricia Sancho, first author of the research paper, “We might be able to exploit this reliance on oxygen by targeting the stem cells with drugs that are already available, killing the cancer by cutting off its energy supply. In the long term, this could mean that pancreatic cancer patients have more treatment options available to them, including a reduced risk of recurrence following surgery and other treatments.”
 
Pancreatic cancer is one of the most difficult types of cancer to treat, because it is usually diagnosed at a late and advanced stage. Many patients do not survive longer than a year post-diagnosis. These cancers have become more common because of obesity, which causes pancreatic cancer risk factors including metabolic syndrome and diabetes. Because of limited treatment options and a failure to improve survival rates, finding new treatment strategies is a priority.
 
The researchers believe that PancSCs could be an important but as yet overlooked piece of this puzzle. While they make up only a small part of the tumor, they have the potential to create new tumors, even if all the other cells are killed, and are prone to metastasis.
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUN 27, 2018
Cancer
JUN 27, 2018
Engineered Poliovirus in Clinical Trials for Glioblastoma
Glioblastoma is a very difficult cancer to treat; researchers look to an engineered poliovirus for novel targeted approach for grade IV patients....
JUN 27, 2018
Infographics
JUN 27, 2018
The Role of Biomarkers In Modern Medicine
A biomarker (short for biological marker) is a measurable indicator of some biological state or condition. The biomarker can be measured objectively and consistently. Biomarkers play signific...
JUL 10, 2018
Cancer
JUL 10, 2018
The ALFRED Analysis for Cancer Predisposition Genes
New proposed statistical method called ALFRED used to identify cancer predisposition genes....
JUL 18, 2018
Immunology
JUL 18, 2018
Immunotherapy Increases Survival of Melanoma Brain Metastases Patients
Use of Checkpoint Blockade Immunotherapy increases survival rates in Melanoma Brain Metastases patients, with a 4-year survival rate increase from 11.1% to 28.1%...
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
OCT 04, 2018
Videos
OCT 04, 2018
Zebrafish as Metastatic Cancer Model
Another Koch Institute Image Award winner from 2018 is presented in this video from MIT....
Loading Comments...